A weightlifter describes months of fatigue and twitching after BPC-157, while FDA advisers appointed under RFK Jr. voted to ease limits on six unapproved peptides.
Recap by typeshit. Full story at CNN.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
The drug behind Mounjaro and Zepbound held back tumor growth in mouse studies. It's early animal work, but obesity is tied to higher breast cancer risk.
A quick clip from Dr Nadolsky with a single recommendation for people on GLP-1 drugs. The habit itself isn't named in the caption.
Loading…